Compliance Governance Pharmaceutical Industry 
Dot Compliance
MAY 3, 2024
In the pharmaceutical industry, the importance of regulatory compliance extends beyond fulfilling legal obligations. Compliance can be streamlined with the help of an electronic quality management system (eQMS) that incorporates regulatory standards into every operational aspect of a pharmaceutical organization.
HIT Consultant
OCTOBER 13, 2024
In addition to regulatory fines triggered by compliance violations, failing to manage data accurately could lead to issues like the sale of expired medications, causing harm to patients. Best practices for managing pharmaceutical data Again, there are no simple solutions for streamlining data management in the pharmaceutical industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
DECEMBER 15, 2023
Confidentiality Laws and regulations govern the confidentiality of medical data. However, it is crucial to consider the compliance of chatbots with security standards. About Natalie Tkachenko Natalie is a HIPAA-certified expert with high-grade knowledge in the healthcare and pharmaceutical industries.
HIT Consultant
DECEMBER 18, 2023
Confidentiality Laws and regulations govern the confidentiality of medical data. However, it is crucial to consider the compliance of chatbots with security standards. State documents define rules for collecting, storing, processing, and transmitting medical information. Currently, ChatGPT does not meet HIPAA standards.
Verisys
JULY 13, 2023
How to Tackle Pharma’s 3 Biggest Compliance Risks Head-On with Verisys How often have you started at a new organization and heard these phrases? “ Some companies make decisions based on compliance standards and optics, while others may be more lax. Clinical trial compliance can offer unique challenges for pharmaceutical companies.
SQA
AUGUST 2, 2021
This technical report focuses on the challenges facing the pharmaceutical industry that use complex packaging systems for sterile drugs and biologics (e.g., government agencies and the private sector to collaborate in providing Americans with timely access to pharmaceuticals.
Bill of Health
MAY 22, 2023
The selections feature topics ranging from an analysis of government and industry investments for recently approved drugs, to a discussion of court decisions on mifepristone, and an examination of the added therapeutic benefit associated with the top-selling brand-name drugs in Medicare. JAMA Health Forum. 2023 Apr 7;4(4):e230511.
Expert insights. Personalized for you.
52 
Let's personalize your content